SpringerProtocols: Abstract: Animal Models of Spontaneous Autoimmune Disease: Type 1 Diabetes in the Nonobese Diabetic Mouse

Animal Models of Spontaneous Autoimmune Disease: Type 1 Diabetes in the Nonobese Diabetic Mouse

By: Nadia Giarratana², Giuseppe Penna², Luciano Adorini²

Abstract

Full Text

Download PDF (228K)

The nonobese diabetic (NOD) mouse represents probably the best spontaneous model for a human autoimmune disease. It has provided not only essential information on type 1 diabetes (T1D) pathogenesis, but also valuable insights into mechanisms of immunoregulation and tolerance. Importantly, it allows testing of immunointervention strategies potentially applicable to man. The fact that T1D incidence in the NOD mouse is sensitive to environmental conditions, and responds, sometimes dramatically, to immunomanipulation, does not represent a limit of the model, but is likely to render it even more similar to its human counterpart. In both cases, macrophages, dendritic cells, CD4⁺, CD8⁺, and B cells are present in the diseased islets. T1D is a polygenic disease, but, both in human and in NOD mouse T1D, the primary susceptibility gene is located within the MHC. On the other hand, T1D incidence is significantly higher in NOD females, although insulitis is similar in both sexes, whereas in humans, T1D occurs with about equal frequency in males and females. In addition, NOD mice have a more widespread autoimmune disorder, which is not the case in the majority of human T1D cases. Despite these differences, the NOD mouse remains the most representative model of human T1D, with similarities also in the putative target autoantigens, including glutamic acid decarboxylase IA-2, and insulin.

Affiliation(s): (2) BioXell, Milan, Italy

Book Title: Immunological Tolerance: Methods and Protocols

Series: Methods in Molecular Biology | Volume: 380 | Pub. Date: Jun-08-2007 | Page Range: 285-311 | DOI: 10.1007/978-1-59745-395-0_17

Subject: Immunology

Key Words: Autoimmunity - type 1 diabetes - NOD mouse - tolerance - immunoregulation

References

Download References

1.	Bach, J.-F. (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev. 15, 516–542.

2.	Adorini, L., Gregori, S., and Harrison, L. (2002) Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med. 8, 31–38.

3.	Kikutani, H. and Makino, S. (1992) The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51, 285–322.

4.	Serreze, D. V., Gaedeke, J. W., and Leiter, E. H. (1993) Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. USA 90, 9625–9629.

5.	Kataoka, S., Satoh, J., Fujiya, H., et al. (1983) Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32, 247–253.

6.	Ogasawara, K., Hamerman, J. A., Hsin, H., et al. (2003) Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18, 41–51.

7.	Naumov, Y. N., Bahjat, K. S., Gausling, R., et al. (2001) Activation of CD1 d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98, 13,838–13,843.

8.	Wang, Geng, Y. and Wang, R. (2001) CD 1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320.

9.	Salomon, B., Lenschow, D. J., Rhee, L., et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440.

10.	Gregori, S., Giarratana, N., Smiroldo, S., and Adorini, L. (2003) Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171, 4040–4047.

11.	Baxter, A. G. and Cooke, A. (1993) Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 42, 1574–1578.

12.	Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K., and Tochino, Y. (1980) Breeding of a non-obese, diabetic stain of mice. Exp. Animal 29, 1–13.

13.	Pozzilli, P., Signore, A., Williams, A. J., and Beales, P. E. (1993) NOD mouse colonies around the world: recent facts and figures. Immunol. Today 14, 193–196.

14.	Andre, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C., and Mathis, D. (1996) Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA 93, 2260–2263.

15.	Yoon, J. W. (1990) The role of viruses and environmental factors in the induction of diabetes. Curr. Top. Microbiol. Immunol. 164, 95–123.

16.	Yoon, J. W. (1992) Induction and prevention of type 1 diabetes mellitus by viruses. Diabete Metab. 18, 378–386.

17.	Davydova, B., Harkonen, T., Kaialainen, S., Hovi, T., Vaarala, O., and Roivainen, M. (2003) Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J. Med. Virol. 69, 510–520.

18.	Bach, J. F. (2005) Infections and autoimmune diseases. J. Autoimmun. 25, 74–80.

19.	Williams, A. J., Krug, J., Lampeter, E. F., et al. (1990) Raised temperature reduces the incidence of diabetes in the NOD mouse. Diabetologia 33, 635–637.

20.	Like, A. A. and Rossini, A.A. (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417.

21.	Malaisse, W. J. (1982) Alloxan toxicity to the pancreatic B cell. A new hypothesis. Biochem. Pharmacol. 31, 3527–3534.

22.	Kolb, H. and Kroencke, K.-D. (1993) IDDM. Lessons from the low-dose streptozocin model in mice. Diabetes Rev. 1, 116–126.

23.	Cossel, L., Schneider, E., Kuttler B, et al. (1985) Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings. Exp. Clin. Endocrinol. 85, 7–26.

24.	Gerling, I. C., Friedman, H., Greiner, D. L., Shultz, L. D., and Leiter, E.H. (1994) Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes 43, 433–440.

25.	Harada, M. and Makino, S. (1984) Promotion of spontaneous diabetes in nonobese diabetes-prone mice by cyclophosphamide. Diabetologia 27, 604–606.

26.	Kay, T. W., Campbell, I. L., and Harrison, L. (1991) Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. J. Autoimmun. 4, 263–276.

27.	Yasunami, R. and Bach, J.-F. (1988) Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18, 481–484.

28.	Christianson, S. W., Shultz, L. D., and Leiter, E. H. (1993) Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4⁺ and CD8⁺ T-cells from diabetic versus prediabetic NOD.NON-Thy-1^a donors. Diabetes 42, 44–55.

29.	Wicker, L. S., Miller, B. J., and Mullen, Y. (1986) Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35, 855–860.

30.	Bendelac, A., Carnaud, C., Boitard, C., and Bach, J.-F. (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4⁺ and Lyt-2⁺ T cells. J. Exp. Med. 166, 823–832.

31.	Wong, F. S., Visintin, I., Wen, L., Flavell, R. A., and Janeway, A., Jr. (1996) CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183, 67–76.

32.	Haskins, K. and Wegmann, D. (1996) Diabetogenic T-cell clones. Diabetes 45, 1299–1305.

33.	Chatenoud, L., Thervet, E., Primo, J., and Bach, J.F. (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91, 123–127.

34.	Wang, B., Gonzales, A., Benoist, C., and Mathis, D. (1996) The role of CD8⁺ cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26, 1762–1769.

35.	Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K., and Fathman, G. (1988) Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240, 659–662.

36.	Kurasawa, K., Sakamoto, A., Maeda, T., et al. (1993) Short-term administration of anti-L3T4 MoAb prevents diabetes in NOD mice. Clin. Exp. Immunol. 91, 376–380.

37.	Mori, Y., Suko, M., Okudaira, H., et al. (1986) Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia 29, 244–247.

38.	Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., and Tisch, R. M. (1998) B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161, 3912–3918.

39.	Wicker, L., Todd, J., and Peterson, L. (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13, 179–200.

40.	Falcone, M. and Sarvetnick, N. (1999) Cytokines that regulate autoimmune responses. Curr. Opin. Immunol. 11, 670–676.

41.	Balasa, B., A. La Cava, K. Van Gunst, L., et al. (2000) A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes. J. Immunol. 165, 7330.

42.	Kawamoto, S., Nitta, Y., Tashiro, F., et al. (2001) Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10. Int. Immunol. 13, 685–694.

43.	Green, E. A., Eynon, E. E., and Flavell, R.A. (1998) Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9, 733–743.

44.	Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D. E., Janeway A., Jr.,and Flavell, R.A. (1996) Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184, 1963–1974.

45.	Wong, S., Guerder, S., Visintin, I., et al. (1995) Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse. Diabetes 44, 326–329.

46.	Lenschow, D. J., Herold, K. C., Rhee, L., et al. (1996) CD28/B7 regulation of TH1 and TH2 subsets in the development of autoimmune diabetes. Immunity 5, 285–293.

47.	Hulbert, C., Riseili, B., Rojas, M., and Thomas, J. (2001) B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J. Immunol. 167, 5535–5538.

48.	Petrovsky, N., Silva, D., Socha, L., Slattery, R., and Charlton, B. (2002) The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice. Ann. NYAcad. Sci. 958, 204–208.

49.	Savinov, A., Tcherepanov, A., Green, E., Flavell, R., and Chervonsky, A. (2003) Contribution of Fas to diabetes development. Proc. Natl. Acad. Sci. USA 100, 628–632.

50.	Sung, H., Juang, J., Lin, Y., et al. (2004) Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J. Exp. Med. 199, 1143–1151.

51.	Katz, J., Benoist, C., and Mathis, D. (1993) Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23, 3358–3360.

52.	Wicker, L. S., Leiter, E. H., Todd, J.A., et al. (1994) Beta 2-microglobulindeficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 500–504.

53.	Mora, C., Wong, F. S., Chang, H., and Flavell, R.A. (1999) Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J. Immunol. 162, 4576–4588.

54.	Kay, T. W. H., Parker, J. L., Stephens, L. A., Thomas, H. E., and Allison, J. (1996) RIP-b2-microglobulin transgene expression restores insulitis, but not diabetes, in b₂-microglobulin^null nonobese diabetic mice. J. Immunol. 157, 3688–3693.

55.	Trembleau, S., Germann, T., Gately, M. K., and Adorini, L. (1995) The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16, 383–386.

56.	Trembleau, S., Penna, G., Gregori, S., et al. (1999) Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J. Immunol. 163, 2960–2968.

57.	Trembleau, S., Penna, G., Gregori, S., Giarratana, N., and Adorini, L. (2003) IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-inducedIFN-gamma. J. Immunol. 170, 5491–5501.

58.	Balasa, B., Van Gunst, K., Jung, N., Katz, J. D., and Sarvetnick, N. (2000) IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell. Immunol. 202, 97–102.

59.	Wang, B., Gonzalez, A., Hoglund, P., Katz, J. D., Benoist, C., and Mathis, D. (1998) Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47, 1207–1211.

60.	Falcone, M., Yeung, B., Tucker, L., Rodriguez, E., Krahl, T., and Sarvetnick, N. (2001) IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets. Clin. Immunol. 98, 190–199.

61.	Green, E. A., Wong, F. S., Eshima, Mora, and Flavell, R. A. (2000) Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells. J. Exp. Med. 191, 225–238.

62.	Martin, S., van den Engel, N., Vinke, A., Heidenthal, E., Schulte, B., and Kolb, H. (2001) Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. J. Autoimmun. 17, 109.

63.	Anderson, M. S., Venanzi, E. S., Chen, Z., Berzins, S. P., Benoist, C., and Mathis, D. (2005) The cellular mechanism of Aire control of T cell tolerance. Immunity 23, 227–239.

64.	Villasenor, J., Benoist, C., and Mathis, D. (2005) AIRE and APECED: molecular insights into an autoimmune disease. Immunol. Rev. 204, 156–164.

65.	Lohmann, T., Leslie, R. D., and Londei, M. (1996) T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun. 9, 385–389.

66.	Semana, G., Gausling, R., Jackson, R. A., and Hafler, D. A. (1999) T cell autore-activity to proinsulin epitopes in diabetic patients and healthy subjects. J. Autoimmun. 12, 259–267.

67.	Miyazaki, T., Uno, M., Uehira, M., et al. (1990) Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 345, 722–724.

68.	Nishimoto, H., Kikutani, H., Yamamura, K. L, and Kishimoto, T. (1987) Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328, 432–434.

69.	Uehira, M., Onu, M., Miyazaki, J., Nishimoto, H., Kishimoto, T., and Yamamura, K. (1989) Development of autoimmune insulitis is prevented in E alpha d but not in A beta k NOD transgenic mice. Int. Immunol. 1, 209–213.

70.	Lund, T., O’Reilly, L., Hutchings, P., et al. (1990) Prevention of insulin-dependent diabetes in non-obese diabetic mice by transgenes encoding modified I-A b-chain or normal I-E a-chain. Nature 345, 727–729.

71.	Boehme, J., Schuhbaur, B., Kanagawa, O., Benoist, C., and Mathis, D. (1990) MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 249, 293–295.

72.	Trembleau, S., Gregori, S., Penna, G., Gorny, I., and Adorini, L. (2001) IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule. J. Immunol. 167, 4104–4114.

73.	Schmidt, D., Amrani, A., Verdaguer, J., Bou, S., and Santamaria, P. (1999) Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules. J. Immunol. 162, 4627–4636.

74.	Carrasco-Marin, E., Shimizu, J., Kanagawa, O., and Unanue, E. (1996) The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156, 450–458.

75.	Ridgway, W. M. and Fathman, C. G. (1999) MHC structure and autoimmune T cell repertoire development. Curr. Opin. Immunol. 11, 638–642.

76.	Harrison, L. C., Honeyman, M. C., Trembleau, S., et al. (1997) A peptide-binding motif for I-Ag7, the class II MHC molecule of NOD and Biozzi AB/H mice. J. Exp. Med. 185, 1013–1021.

77.	Corper, A. L., Stratmann, T., Apostolopoulos, V., et al. (2000) A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288, 505–511.

78.	French, M., Allison, J., Cram, D. S., et al. (1997) Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46, 34–39.

79.	Wong, F. S., Karttunen, J., Dumont, C., et al. (1999) Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5, 1026–1031.

80.	Yoon, J. W., Yoon, S., Lim, H. W., et al. (1999) Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284, 1183–1187.

81.	Ranheim, E. A., Tarbell, K., Krogsgaard, M., et al. (2004) Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene. Autoimmunity 37, 555–567.

82.	Trembleau, S., Penna, G., Gregori, S., Magistrelli, G., Isacchi, A., and Adorini, L. (2000) Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. J. Immunol. 165, 6748–6755.

83.	Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K., and Adorini, L. (1995) IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181, 817–821.

84.	Nitta, Y., Kawamoto, S., Tashiro, F., et al. (2001) IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice. J. Autoimmun. 16, 97–104.

85.	Serreze, D. V., Chapman, H. D., Post, M., Johnson, E. A., Suarez-Pinzon, W. L., and Rabinovitch, A. (2001) Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 166, 1352–1359.

86.	Mueller, R., Krahl, T., and Sarvetnick, N. (1996) Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184, 1093–1099.

87.	Mueller, R., Bradley, L. M., Krahl, T., and Sarvetnick, N. (1997) Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity 7, 411–418.

88.	Pakala, S. V., Kurrer, M. O., and Katz, J. D. (1997) T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186, 299–306.

89.	Godfrey, D. L, Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. (2000) NKT cells: facts, functions and fallacies. Immunol. Today 21, 573–583.

90.	Hammond, K. J., Pellicci, D. G., Poulton, L. D., et al. (2001) CD 1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167, 1164–1173.

91.	Baxter, A. G., Kinder, S. J., Hammond, J., Scollay, R., and Godfrey, D. I. (1997) Association between alphabetaTCR+CD4-CD8-T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46, 572–582.

92.	Hammond, J., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., and Baxter, A. G. (1998) alpha/beta-T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187, 1047–1056.

93.	Lehuen, A., Lantz, O., Beaudoin, L., et al. (1998) Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831–1839.

94.	Sharif, S., Arreaza, G. A., Zucker, P., et al. (2001) Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7, 1057–1062.

95.	Hong, S., Wilson, M. T., Serizawa, I., et al. (2001) The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7, 1052–1056.

96.	Shi, F. D., Flodstrom, M., Balasa, B., et al. (2001) Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 98, 6777–6782.

97.	Shevach, E. M. (2000) Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18, 423–449.

98.	Lepault, F. and Gagnerault, M. (2000) Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164, 240–247.

99.	Hanninen, A. and Harrison, L. (2000) Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173, 109–119.

100.	Sakaguchi, S.(2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455–458.

101.	Shevach, E. M. (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389.

102.	Hori, S., Nomura, T., and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061.

103.	Fontenot, J. D., Gavin, M.A., and Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat. Immunol. 4, 330–336.

104.	Khattri, R., Yasayko, S. A., and Ramsdell, F. (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337–342.

105.	Read, S., Malmstrom, V., and Powrie, F. (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302.

106.	Stephens, L. A. and Mason, D. (2000) CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25-subpopulations. J. Immunol. 165, 3105–3110.

107.	Wu, A. J., Hua, H., Munson, S. H., and McDevitt, H. (2002) Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99, 12,287–12,292.

108.	Chen, Z., Benoist, C., and Mathis, D. (2005) How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc. Natl. Acad. sei. USA 102, 14,735–14,740.

109.	Szanya, V., Ermann, J., Taylor, C., Holness, C., and Fathman, G. (2002) The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169, 2461–2465.

110.	Tang, Q., Henriksen, K. J., Bi, M., et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465.

111.	Horwitz, D. A., Zheng, S. G., Gray, J. D., Wang, J. H., Ohtsuka, K., and Yamagiwa, S. (2004) Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. 16, 135–143.

112.	Zheng, S. G., Wang, J. H., Gray, J. D., Soucier, H., and Horwitz, D.A. (2004) Natural and induced CD4+CD25+ cells educate CD4+CD25-cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172, 5213–5221.

113.	Yamazaki, S., Iyoda, T., Tarbell, K., et al. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235–247.

114.	Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P., and Steinman, R.M. (2004) CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoanti-genic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467–1477.

115.	Belghith, M., Bluestone, J. A., Barriot, S., Megret, J., Bach, J. F., and Chatenoud, L. (2003) TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9, 1202–1208.

116.	Peng, Y., Laouar, Y., Li, M. O., Green, E. A., and Flavell, R. A. (2004) TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sei USA 101, 4572–4577.

117.	Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., and Neurath, M. F. (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25-T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149–5153.

118.	Atkinson, M. A. and Wilson, S.B. (2002) Fatal attraction: chemokines and type 1 diabetes. J. Clin. Invest. 110, 1611–1613.

119.	Grattan, M., Mi, Q. S., Meagher, C., and Delovitch, T. L. (2002) Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51, 215–223.

120.	Chen, M., Schuit, F., and Eizirik, D. L. (1999) Identification of IL-1beta-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA. Diabetologia 42, 1199–1203.

121.	Frigerio, S., Junt, T., Lu, et al. (2002) Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 8, 1414–1420.

122.	Giarratana, N., Penna, G., Amuchastegui, S., Mariani, R., Daniel, K.C., and Adorini, L. (2004) A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J. Immunol. 173, 2280–2287.

123.	Rossi, D. and Zlotnik, A. (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217–242.

124.	Denny, P., Lord, J., Hill, N.J., et al. (1997) Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 46, 695–700.

125.	Knoechel, B., Lohr, J., Kahn, E., Bluestone, J. A., and Abbas, A.K. (2005) Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202, 1375–1386.

126.	Refaeli, Y., Van Parijs, L., and Abbas, A.K. (1999) Genetic models of abnormal apoptosis in lymphocytes. Immunol. Rev. 169, 273–282.

127.	Colucci, F., Bergman, M.-L., Penha-Goncalves, C., Cilio, M., and Holmberg, D. (1997) Apoptosis resistance of NOD peripheral lymphocytes linked to the idd5 diabetes susceptibility region. Proc. Natl. Acad. Sci. USA 94, 8670–8674.

128.	Gonzalez, A., Katz, J. D., Mattei, M. G., Kikutani, H., Benoist, C., and Mathis, D. (1997) Genetic control of diabetes progression. Immunity 7, 873–883.

129.	Quartey-Papafio, R., Lund, T., Chandler, P., et al. (1995) Aspartate at position 57 of nonobese diabetic I-Ag7 b-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. J. Immunol. 154, 5567–5575.

130.	Singer, S., Tisch, R., Yang, X. D., and McDevitt, H.O. (1993) An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA 90, 9566–9570.

131.	Slattery, R. M., Kjer-Nielsen, L., Allison, J., Charlton, B., Mandel, T. E., and Miller, J. F. (1990) Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 345, 724–726.

132.	Lawrance, S. K., Karlsson, L., Price, J., et al. (1989) Transgenic HLA-DRa faithfully reconstitutes I-E-controlled immune functions and induces cross-tolerance to Ea in Ea° mutant mice. Cell 58, 583–594.

133.	Liu, J., Purdy, L. E., Rabinovitch, S., Jevnikar, A.M., and Elliott, J. F. (1999) Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA10301, DQB10302 transgenic IA(null) NOD mice. Diabetes 48, 469–477.

134.	Fukui, Y., Nishimura, Y., Iwanga, T., et al. (1989) Glycosuria and insulitis in NOD mice expressing the HLA-DQw6 molecule. J. Immunogenet. 16, 445–453.

135.	Miyazaki, T., Matsuda, Y., Toyonaga, T., Miyazaki, J., Yazaki, Y., and Yamamura, K. (1992) Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules. Proc. Natl. Acad. Sci. USA 89, 9519–9523.

136.	Allison, J., McClive, P., Oxbrow, L., Baxter, A., Morahan, G., and Miller, J. F. A. P. (1994) Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells. Eur. J. Immunol. 24, 2535–2541.

137.	DiCosmo, B. R, Picarella, D., and Flavell, R. A. (1994) Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice. Int. Immunol. 6, 1829–1837.

138.	Wogensen, L., Lee, M.-S., and Sarvetnick, N. (1994) Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp. Med. 179, 1379–1384.

139.	Moritani, M., Yoshimoto, K., Tashiro, F., et al. (1994) Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6, 1927–1936.

140.	King, C., Davies, J., Mueller, R., et al. (1998) TGF-beta1 alters APC preference, polarizing islet antigen responses toward aTh2 phenotype. Immunity 8, 601–613.

141.	Nakayama, M., Abiru, N., Moriyama, H., et al. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435, 220–223.

142.	Birk, O. S., Douek, D. C., Elias, D., et al. (1996) A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc. Natl. Acad. sei. USA 93, 1032–1037.

143.	Geng, L., Solimena, M., Flavell, R. A., Sherwin, R.S., and Hayday, A. C. (1998) Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease. Proc. Natl. Acad. Sci. USA 95, 10,055–10,060.

144.	Katz, J. D., Wang, B., Haskins, K., Benoist, C., and Mathis, D. (1993) Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089–1100.

145.	Verdaguer, J., Yoon, J. W., Anderson, B., et al. (1996) Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. J. Immunol. 157, 4726–4735.

146.	Kim, S. K., Tarbell, K. V., Sanna, M., et al. (2004) Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc. Natl. Acad. Sci. USA 101, 14,204–14,209.

147.	Hultgren, B., Huang, X., Dybdal, N., and Stewart, T. A. (1996) Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45, 812–817.

148.	Kanagawa, O., Xu, G., Tevaarwerk, A., and Vaupel, B. A. (2000) Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci. J. Immunol. 164, 3919–3923.

149.	Kagi, D., Ho, A., Odermatt, B., Zakarian, A., Ohashi, P. S., and Mak T. W. (1999) TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J. Immunol. 162, 4598–4605.

150.	Thebault-Baumont, K., Dubois-Laforgue, D., Krief, P., et al. (2003) Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J. Clin. Invest. 111, 851–857.

151.	Luhder, F., Chambers, C., Allison, J.P., Benoist, C., and Mathis, D. (2000) Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc. Natl. Acad. Sci. USA 97, 12,204–12,209.

152.	Serreze, D. V., Chapman, H. D., Varnum, D.S., et al. (1996) B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new “speed congenic” stock of NOD.Ig mu null mice. J. Exp. Med. 184, 2049–2053.

153.	Kagi, D., Odermatt, B., Ohashi, P.S., Zinkernagel, R.M., and Hengartner, H. (1996) Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183, 2143–2152.

Comments (Loading...)

Post comment/View all comments